IV 튜브 세트 및 부속품 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, IV tubing sets & accessories market size in 2026 is estimated at USD 1.53 billion, growing from 2025 value of USD 1.45 billion with 2031 projections showing USD 1.98 billion, growing at 5.33% CAGR over 2026-2031.

This report is Segmented by Product (Primary IV Tubing Sets, Secondary IV Tubing Sets, Extension IV Tubing Sets, IV Tubing Accessories, Others), Application (Central Venous Catheter Placement, and More), End User (Hospitals, Ambulatory Surgical Centers, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global IV Tubing Sets And Accessories Market Trends and Insights

Rapid Growth in Home-Infusion Therapies

Home infusion has shifted the IV tubing sets & accessories market by moving demand from short hospital stays to prolonged outpatient use. Payers now reimburse parenteral nutrition and chemotherapy administered at home, which requires tubing with higher durability and user-friendly connectors. The FDA has released guidance emphasizing closed pathways and needle-free valves to prevent contamination in settings without continuous clinical supervision. Smart pumps paired with RFID-tagged tubing allow remote monitoring, so caregivers receive alerts when flow deviates from prescribed parameters. As providers adopt these systems, manufacturers that bundle consumables with cloud-connected pumps secure sticky revenue streams. The shift also reduces inpatient costs, a point that aligns with health system strategies focused on lowering readmission penalties.

Shift Toward Needle-Free Closed IV Systems

Needle-free connectors reduce occupational exposure and cut the number of breach points that can harbor pathogens. California's AB 2300 law sparked broader adoption by mandating closed systems in acute-care facilities, a template many states and countries now emulate . Clinical studies show decreased catheter-related bloodstream infections when connectors incorporate mechanical valves that stay closed unless positively displaced. Market leaders respond with antimicrobial coatings and color-change indicators that confirm proper disinfection. Training remains essential because poor scrubbing technique negates device benefits. Early adopters in the United States influence purchasing behavior in Asia-Pacific, where hospitals upgrading to Joint Commission International standards must include closed-system components.

Stringent Regulatory Framework

The FDA and European MDR both demand real-world evidence before approving new tubing materials, lengthening development cycles and raising compliance costs. Notified-body bottlenecks in Europe delay market entry for smaller innovators. Cybersecurity clauses extend to any tubing that communicates with connected pumps, adding penetration testing and documentation steps unheard of a decade ago. While these rules favor entrenched firms with dedicated regulatory teams, they also slow innovation in niche segments such as pediatric oncology where specialized tubing could lower error rates. Start-ups often partner with established OEMs to piggyback on existing quality systems, but profit sharing erodes their margins.

Other drivers and restraints analyzed in the detailed report include:

1. Rising Surgical Volumes in Emerging Economies
2. Government Initiatives Improving Vascular-Access Safety
3. Plasticizer and PVC-Phthalate Bans

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Primary IV tubing sets accounted for 45.12% of revenue in 2025, underpinning the procedural backbone of routine hydration and antibiotic administration across all care settings. Their high installed base and standardized connectors keep them indispensable, anchoring bulk-purchase contracts that underpin the IV tubing sets & accessories industry. Yet the same contracts increasingly bundle secondary tubing, a category forecast to grow at 6.11% CAGR as clinicians adopt multi-drug regimens that call for parallel infusions without pausing the primary line. This rise dovetails with smart pumps that auto-adjust flow through each lumen, ensuring precise dosing even in home settings. Manufacturers add value by integrating anti-siphon valves and back-check features, enhancing safety while justifying moderate price premiums.

Extension sets and accessory portfolios expand as providers seek ergonomic options that reduce line restarts when repositioning patients. Demand intensifies in critical-care units where equipment density requires flexible routing solutions. Blood administration sets and chemotherapy-grade lines fall under the Others category, where chemical compatibility and light-blocking materials command premium prices. RFID tagging within select tubing ranges allows the pump to authenticate each set, reducing misload events. As digital traceability becomes routine, proprietary connectors strengthen lock-in effects, influencing the IV tubing sets & accessories market size tied to replacement cycles.

Complete Report Scope:

• By Product
  • Primary IV Tubing Sets
  • Secondary IV Tubing Sets
  • Extension IV Tubing Sets
  • IV Tubing Accessories
  • Others
• By Application
  • Central Venous Catheter Placement
  • Peripheral Intravenous Catheter Insertion
  • PICC Line Insertion
  • Others
• By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Home-care Settings
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 41.55% of global revenue in 2025, strengthened by early adoption of closed-system connectors, stringent OSHA mandates, and bundled multi-product contracts that include pumps, solutions, and disposables. Hurricanes and pandemic-related freight disruptions exposed supply chain weaknesses, prompting U.S. manufacturers to invest almost USD 1 billion in domestic capacity that cushions against future shocks. Regional payers now reimburse infection-prevention add-ons, which encourages hospitals to pay a premium for antimicrobial ports and RFID-enabled sets.

Asia-Pacific posts the fastest regional CAGR at 6.27% through 2031, fueled by rising surgical caseloads and expansion of public insurance schemes in China and India. Volume-based procurement models encourage bulk orders of standardized tubing, yet regulators simultaneously tighten safety criteria, creating a two-tier market. Local firms win spot tenders on price, whereas multinational brands capture tertiary hospitals that prioritize infection metrics for medical tourism. APAC governments also channel grants into smart-pump pilots, driving accompanying demand for compatible tubing coded with GS1 identifiers.

Europe occupies the second-largest share, anchored by evidence-based procurement guidelines that stress clinical data over headline price. The post-Brexit regulatory split raised compliance costs, compelling manufacturers to maintain parallel EU and UK submissions. Germany and France continue to favor premium closed systems, while Eastern European hospitals climb the maturity curve. Middle East and Africa register early-stage adoption, yet Gulf Cooperation Council investments in flagship medical cities generate pockets of high-value demand. South America's growth is steadier; Brazil's economic rebound and Argentina's currency stabilization unlock new device purchases, though import duties influence price positioning.

1. B. Braun
2. Baxter
3. Fresenius
4. ICU Medical
5. BD (Becton, Dickinson & Co.)
6. Smiths Group
7. Terumo
8. Nipro
9. Polymedicure Ltd.
10. Vygon
11. Codan Medizinische Gerate
12. AngioDynamics
13. Grifols
14. Moog
15. Zyno Medical
16. AdvaCare
17. Jiangsu Huida Medical Instruments
18. Medline Industries
19. Q Medical Industries
20. Amsino International

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rapid growth in home-infusion therapies
  • 4.2.2 Shift toward needle-free closed IV systems
  • 4.2.3 Rising surgical volumes in emerging economies
  • 4.2.4 Increasing natality rate
  • 4.2.5 Government initiatives improving vascular-access safety
  • 4.2.6 AI-enabled predictive maintenance of IV equipment
• 4.3 Market Restraints
  • 4.3.1 Stringent regulatory framework
  • 4.3.2 Plasticizer & PVC-phthalate bans
  • 4.3.3 Supply-chain fragility for medical-grade resins
  • 4.3.4 Increasing recalls tied to flow-rate inaccuracy
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product
  • 5.1.1 Primary IV Tubing Sets
  • 5.1.2 Secondary IV Tubing Sets
  • 5.1.3 Extension IV Tubing Sets
  • 5.1.4 IV Tubing Accessories
  • 5.1.5 Others
• 5.2 By Application
  • 5.2.1 Central Venous Catheter Placement
  • 5.2.2 Peripheral Intravenous Catheter Insertion
  • 5.2.3 PICC Line Insertion
  • 5.2.4 Others
• 5.3 By End User
  • 5.3.1 Hospitals
  • 5.3.2 Ambulatory Surgical Centers
  • 5.3.3 Home-care Settings
  • 5.3.4 Others
• 5.4 By Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 B. Braun Melsungen AG
  • 6.3.2 Baxter International Inc.
  • 6.3.3 Fresenius Kabi AG
  • 6.3.4 ICU Medical Inc.
  • 6.3.5 BD (Becton, Dickinson & Co.)
  • 6.3.6 Smiths Medical
  • 6.3.7 Terumo Corporation
  • 6.3.8 Nipro Corporation
  • 6.3.9 Polymedicure Ltd.
  • 6.3.10 Vygon SA
  • 6.3.11 Codan Medizinische Gerate
  • 6.3.12 AngioDynamics Inc.
  • 6.3.13 Grifols SA
  • 6.3.14 Moog Inc.
  • 6.3.15 Zyno Medical LLC
  • 6.3.16 AdvaCare Pharma
  • 6.3.17 Jiangsu Huida Medical Instruments
  • 6.3.18 Medline Industries LP
  • 6.3.19 Q Medical Industries
  • 6.3.20 Amsino International Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment